C Demosthenous1,2, G Rizos1, E Vlachaki3, G Tzatzagou1, M Gavra1. 1. 1 Department of Internal Medicine, Papageorgiou General Hospital, Thessaloniki, Greece. 2. Department of Hematology and HCT Unit, George Papanicolaou General Hospital, Thessaloniki, Greece. 3. 2 Department of Internal Medicine, Hippokration General Hospital of Thessaloniki, Thessaloniki, Greece.
Abstract
BACKGROUND: Hemosiderosis in the absence of blood transfusions has been encountered in conditions associated with ineffective erythropoiesis but not in sickle-cell disease (SCD). Description of the case: We report a case of a 34-year-old Caucasian male, with a history of SCD and beta thalassemia (Hb S/β+-thal) who presented with acute painful crises. Despite never having received regular blood transfusions in the past, the patient demonstrated elevated ferritin levels and transferrin saturation of 83 %. Further evaluation revealed diffuse hepatocellular dysfunction and cirrhosis. CONCLUSION: To the best of our knowledge, this is the first patient with Hb S/β+-thal without a prior history of chronic blood transfusions or other predisposing factors for liver disease who developed hemosiderosis and cirrhosis. The pathomechanism, in this case, is thought to be related to increased duodenal iron uptake secondary to premature red cell precursor death. Further studies are required to characterize ineffective intramedullary erythropoiesis and iron metabolism better, and to improve the existing management guidelines of iron overload. The data reported herein suggest that patients with hemoglobinotpathies should be screened for iron overload regardless of transfusion history. HIPPOKRATIA 2017, 21(1): 43-45.
BACKGROUND:Hemosiderosis in the absence of blood transfusions has been encountered in conditions associated with ineffective erythropoiesis but not in sickle-cell disease (SCD). Description of the case: We report a case of a 34-year-old Caucasian male, with a history of SCD and beta thalassemia (Hb S/β+-thal) who presented with acute painful crises. Despite never having received regular blood transfusions in the past, the patient demonstrated elevated ferritin levels and transferrin saturation of 83 %. Further evaluation revealed diffuse hepatocellular dysfunction and cirrhosis. CONCLUSION: To the best of our knowledge, this is the first patient with Hb S/β+-thal without a prior history of chronic blood transfusions or other predisposing factors for liver disease who developed hemosiderosis and cirrhosis. The pathomechanism, in this case, is thought to be related to increased duodenal iron uptake secondary to premature red cell precursor death. Further studies are required to characterize ineffective intramedullary erythropoiesis and iron metabolism better, and to improve the existing management guidelines of iron overload. The data reported herein suggest that patients with hemoglobinotpathies should be screened for iron overload regardless of transfusion history. HIPPOKRATIA 2017, 21(1): 43-45.
Authors: Ellen B Fung; Paul Harmatz; Meredith Milet; Samir K Ballas; Laura De Castro; Ward Hagar; William Owen; Nancy Olivieri; Kim Smith-Whitley; Deepika Darbari; Winfred Wang; Elliott Vichinsky Journal: Am J Hematol Date: 2007-04 Impact factor: 10.047
Authors: Sara Gardenghi; Maria F Marongiu; Pedro Ramos; Ella Guy; Laura Breda; Amy Chadburn; YiFang Liu; Ninette Amariglio; Gideon Rechavi; Eliezer A Rachmilewitz; William Breuer; Z Ioav Cabantchik; Diedra M Wrighting; Nancy C Andrews; Maria de Sousa; Patricia J Giardina; Robert W Grady; Stefano Rivella Journal: Blood Date: 2007-02-13 Impact factor: 22.113
Authors: Philip A Berry; Timothy J S Cross; Swee Lay Thein; Bernard C Portmann; Julia A Wendon; John B Karani; Michael A Heneghan; Adrian Bomford Journal: Clin Gastroenterol Hepatol Date: 2007-09-27 Impact factor: 11.382
Authors: Toshihiko Tanno; Prashanth Porayette; Orapan Sripichai; Seung-Jae Noh; Colleen Byrnes; Ajoy Bhupatiraju; Y Terry Lee; Julia B Goodnough; Omid Harandi; Tomas Ganz; Robert F Paulson; Jeffery L Miller Journal: Blood Date: 2009-05-04 Impact factor: 22.113